Disability News and Research

RSS

Surgical approach to total hip replacement has no impact on outcomes, shows research

The surgical approach to total hip replacement--either from the front of the body or the side/back (anterior versus posterior)--has no impact on outcomes six months after surgery, according to research presented today at the 2016 Annual Meeting of the American Academy of Orthopaedic Surgeons.

4 Mar 2016

Consultation between geriatrician and trauma surgeons improves care of elderly accident victims

An immediate consultation between trauma surgeons and a geriatrician improves multidisciplinary care of elderly accident victims and the sensitivity of the family to the patient's ongoing health care needs.

4 Mar 2016

New MyGene2 web tool may help find genes influencing Mendelian disorders

A new web tool, MyGene2, will enable patients and their families to join clinicians and scientists in the search for genes underlying rare disorders. The sharing of health information also will improve knowledge about how gene variants influence symptoms and other clinical features of Mendelian disorders.

3 Mar 2016

Blueberry Therapeutics set to create safe, effective nanomedicines to tackle unmet healthcare needs

Blueberry Therapeutics Ltd, a leading pharmaceutical company focused on the major medical problems of inflammation and infection, are exploring the anti-microbial agenda through the development of new anti-fungal drugs and treatments to tackle this important unmet healthcare need.

2 Mar 2016

New WHO report highlights ways to prevent, mitigate hearing loss in children

Nearly 32 million children across the world live with disabling hearing loss. A new World Health Organization (WHO) report, Childhood hearing loss: act now, here’s how, suggests that 60% of this can be prevented.

2 Mar 2016

Study finds wide disparities in access to surgery between rich and poor countries

The volume of surgery has increased globally over the last decade but wide disparities in access to surgery persist between rich and poor countries, according to a study published today in the Bulletin of the World Health Organization.

2 Mar 2016

Stemina developing new screening method to diagnose autism

A University of Wisconsin-Madison spinoff is screening blood samples in an effort to develop a biologically based method to diagnose autism.

2 Mar 2016

Vitamin D supplementation during pregnancy can help increase bone strength in babies born in winter months

Vitamin D supplementation during pregnancy may lead to stronger bones in babies born during the winter months, a new Southampton study has shown.

2 Mar 2016

Report: One in two Americans affected by musculoskeletal condition

An estimated 126.6 million Americans (one in two adults) are affected by a musculoskeletal condition--comparable to the total percentage of Americans living with a chronic lung or heart condition--costing an estimated $213 billion in annual treatment, care and lost wages, according to a new report issued today by the United States Bone and Joint Initiative.

2 Mar 2016

CAMH, Impel NeuroPharma partner to advance novel treatment to alleviate depression

The Centre for Addiction and Mental Health and Impel NeuroPharma have signed a licensing agreement to advance a new neuropeptide-based therapeutic approach shown to be effective in treating depression.

1 Mar 2016

Osteopathic manipulative treatment improves function in patients suffering from chronic low back pain

Studies published in the Journal of the American Osteopathic Association found that osteopathic manipulative treatment (OMT) reduced pain and improved function in patients suffering from chronic, nonspecific low back pain.

1 Mar 2016

Are we ageing healthily? An interview with Professor Carol Jagger

This is the million dollar question but it is hard to give a definite answer. Most data on trends in life and healthy life expectancy use surveys that do not include people in care homes which can skew results at older ages.

29 Feb 2016

Phase III study: Ocrelizumab significantly reduces disease activity in PPMS patients

Ocrelizumab (OCR) is a humanized monoclonal antibody that selectively targets CD20+B cells. In a randomized, double-blind, placebo-controlled Phase III study (ORATORIO), OCR significantly reduced disease activity in patients with primary progressive multiple sclerosis (PPMS).

27 Feb 2016

Novel therapeutic approach to target monomeric Tau protein

Dementia and other tauopathies, most notably Alzheimer's disease, embody a class of neurodegenerative diseases associated with the aggregation of the Tau protein in the human brain. These diseases represent one of the leading causes of death and disability in the elderly population in the western world, with no current effective therapy.

27 Feb 2016

Immune-suppressing drug can improve cognitive ability of patients with schizophrenia

A recent study of a handful of patients supports mounting evidence that targeted suppression of inflammation packaged with standard therapy can improve the cognitive ability of patients with schizophrenia, physician-scientists report.

25 Feb 2016

Does simulated based training bring better value healthcare? An interview with Prof Sir Muir Gray, Former Chief Knowledge Officer of the NHS

We have to think of the world that we are leaving, the world we are moving into. The last fifty years in healthcare, have seen the advent of hip replacement, cardiac bypass, systematic reviews. But at the end of fifty years, every country is facing five problems.

24 Feb 2016

College psychology courses lack important information about disabilities

Psychology classes are among the most popular courses on college campuses today, but new research shows that many of them lack important information about the largest single minority group in the U.S. - people with disabilities.

24 Feb 2016

Black, white Americans cope with pain differently

Researchers led by Adam T. Hirsh of the School of Science at Indiana University-Purdue University Indianapolis report that black and white Americans cope with pain differently and that blacks employ pain coping strategies more frequently than whites. The IUPUI review and analysis of 19 studies is the first to examine the entire published literature and quantify the relationship between race and the use of pain-coping strategies.

23 Feb 2016

National Stroke Association reports positive outcomes from Stroke Recovery Navigator program

National Stroke Association released today the promising results from the pilot of its Stroke Recovery Navigator program (SRN) at the International Stroke Conference in Los Angeles.

23 Feb 2016

Cardiac clot-busting drug decreases mortality in hemorrhagic stroke patients

Reporting on the results of a phase III international clinical trial, Johns Hopkins Medicine physicians say use of a cardiac clot-busting drug to treat strokes that cause brain bleeding safely decreased the death rate in patients by 10 percent, compared to a control group receiving saline.

23 Feb 2016

Disability News and Research

Surgical approach to total hip replacement has no impact on outcomes, shows research

Consultation between geriatrician and trauma surgeons improves care of elderly accident victims

New MyGene2 web tool may help find genes influencing Mendelian disorders

Blueberry Therapeutics set to create safe, effective nanomedicines to tackle unmet healthcare needs

New WHO report highlights ways to prevent, mitigate hearing loss in children

Study finds wide disparities in access to surgery between rich and poor countries

Stemina developing new screening method to diagnose autism

Vitamin D supplementation during pregnancy can help increase bone strength in babies born in winter months

Report: One in two Americans affected by musculoskeletal condition

CAMH, Impel NeuroPharma partner to advance novel treatment to alleviate depression

Osteopathic manipulative treatment improves function in patients suffering from chronic low back pain

Are we ageing healthily? An interview with Professor Carol Jagger

Phase III study: Ocrelizumab significantly reduces disease activity in PPMS patients

Novel therapeutic approach to target monomeric Tau protein

Immune-suppressing drug can improve cognitive ability of patients with schizophrenia

Does simulated based training bring better value healthcare? An interview with Prof Sir Muir Gray, Former Chief Knowledge Officer of the NHS

College psychology courses lack important information about disabilities

Black, white Americans cope with pain differently

National Stroke Association reports positive outcomes from Stroke Recovery Navigator program

Cardiac clot-busting drug decreases mortality in hemorrhagic stroke patients

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News